<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">mice </span>
   <span class="font26">protein </span>
   <span class="font26">fusion </span>
   <span class="font25">vaccine </span>
   <span class="font19">enterovirus </span>
   <span class="font18">immunized </span>
   <span class="font17">inactivated </span>
   <span class="font17">neonatal </span>
   <span class="font17">immunization </span>
   <span class="font17">infection </span>
   <span class="font16">candidate </span>
   <span class="font16">[]. </span>
   <span class="font16">{border-style </span>
   <span class="font15">cross-reactivity </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">human </span>
   <span class="font15">virus </span>
   <span class="font15">vaccines </span>
   <span class="font15">viral </span>
   <span class="font14">containing </span>
   <span class="font14">sera </span>
   <span class="font14">used </span>
   <span class="font14">female </span>
   <span class="font14">immune </span>
   <span class="font14">antibodies </span>
   <span class="font14">brain </span>
   <span class="font14">disease </span>
   <span class="font14">protective </span>
   <span class="font14">using </span>
   <span class="font13">effect </span>
   <span class="font13">effects </span>
   <span class="font13">neutralization </span>
   <span class="font13">particles </span>
   <span class="font13">capsid </span>
   <span class="font13">group </span>
   <span class="font13">immunoprotective </span>
   <span class="font13">peptides </span>
   <span class="font13">serum </span>
   <span class="font13">virus-like </span>
   <span class="font12">(Fig. </span>
   <span class="font12">P–, </span>
   <span class="font12">active </span>
   <span class="font12">analysis </span>
   <span class="font12">control </span>
   <span class="font12">negative </span>
   <span class="font12">positive </span>
   <span class="font12">clinical </span>
   <span class="font12">mouse </span>
   <span class="font12">px; </span>
   <span class="font12">{font-family </span>
   <span class="font12"> μg </span>
   <span class="font12">Animal </span>
   <span class="font12">Chinese </span>
   <span class="font12">Enterovirus </span>
   <span class="font12">Infect </span>
   <span class="font12">font-size </span>
   <span class="font12">mice, </span>
   <span class="font12">mouth </span>
   <span class="font12">previously </span>
   <span class="font12">production </span>
   <span class="font12">response </span>
   <span class="font12">tissues </span>
   <span class="font12"> weeks </span>
   <span class="font11">Academy </span>
   <span class="font11">HFMD </span>
   <span class="font11">Human </span>
   <span class="font11">Laboratory </span>
   <span class="font11">NTs </span>
   <span class="font11">RNA </span>
   <span class="font11">booster </span>
   <span class="font11">cases </span>
   <span class="font11">coli </span>
   <span class="font11">data </span>
   <span class="font11">dosage </span>
   <span class="font11">double; </span>
   <span class="font11">foot, </span>
   <span class="font11">group, </span>
   <span class="font11">high </span>
   <span class="font11">immunization, </span>
   <span class="font11">maternal </span>
   <span class="font11">neutralizing </span>
   <span class="font11">protein. </span>
   <span class="font11">scores </span>
   <span class="font11">titers </span>
   <span class="font11"> μL </span>
   <span class="font11"> μg, </span>
   <span class="font11">Commons </span>
   <span class="font11">Creative </span>
   <span class="font11">Fig. </span>
   <span class="font11">Medical </span>
   <span class="font11">National </span>
   <span class="font11">VLPs </span>
   <span class="font11">aged </span>
   <span class="font11">analyzed </span>
   <span class="font11">antibody </span>
   <span class="font11">assembled </span>
   <span class="font11">assessed </span>
   <span class="font11">barrier </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">caused </span>
   <span class="font11">children </span>
   <span class="font11">developed </span>
   <span class="font11">dose </span>
   <span class="font11">effectively </span>
   <span class="font11">immunity </span>
   <span class="font11">increased </span>
   <span class="font11">induced </span>
   <span class="font11">infection. </span>
   <span class="font11">muscle </span>
   <span class="font11">neurological </span>
   <span class="font11">performed </span>
   <span class="font11">prepared </span>
   <span class="font11">prevent </span>
   <span class="font11">protein, </span>
   <span class="font11">proteins </span>
   <span class="font11">respectively. </span>
   <span class="font11">solid; </span>
   <span class="font11">study </span>
   <span class="font11">titer </span>
   <span class="font11">twice </span>
   <span class="font11">vaccinated </span>
   <span class="font11">weak </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">-day-old </span>
   <span class="font11">CPE </span>
   <span class="font11">Determination </span>
   <span class="font11">EV-mediated </span>
   <span class="font11">Immunohistochemical </span>
   <span class="font11">Institute </span>
   <span class="font11">J.L. </span>
   <span class="font11">Protective </span>
   <span class="font11">Science </span>
   <span class="font11">Sciences </span>
   <span class="font11">Thereafter, </span>
   <span class="font11">VLP </span>
   <span class="font11">VP, </span>
   <span class="font11">[], </span>
   <span class="font11">[–]. </span>
   <span class="font11">approved </span>
   <span class="font11">bold </span>
   <span class="font11">born </span>
   <span class="font11">candidate, </span>
   <span class="font11">comprising </span>
   <span class="font11">courier; </span>
   <span class="font11">development </span>
   <span class="font11">em; </span>
   <span class="font11">epidemic </span>
   <span class="font11">experiments </span>
   <span class="font11">expressed </span>
   <span class="font11">fragments </span>
   <span class="font11">fused </span>
   <span class="font11">group. </span>
   <span class="font11">hand, </span>
   <span class="font11">including </span>
   <span class="font11">induce </span>
   <span class="font11">lethal </span>
   <span class="font11">model </span>
   <span class="font11">normal </span>
   <span class="font11">observed </span>
   <span class="font11">obtained </span>
   <span class="font11">permitted </span>
   <span class="font11">pt;} </span>
   <span class="font11">reaction </span>
   <span class="font11">recombinant </span>
   <span class="font11">reported </span>
   <span class="font11">safety </span>
   <span class="font11">tissue </span>
   <span class="font11">virus, </span>
   <span class="font11"> mM </span>
  </p>
 </body>
</html>
